|
Media Releases |
Financial Reports |
Presen-tations |
|
02/10/2006
|
|
|
|
| Lonza grants Genentech License to GS Gene Expression System |
Lonza Group Ltd (SWX:LONN) announces that Lonza has granted Genentech, Inc. (NYSE:DNA) a non-exclusive, worldwide license to their GS Gene Expression System. The research evaluation agreement covers use of the GS System for research and development purposes. The agreement includes options for a Multi Product License to the GS System for commercial purposes, and further options to obtain licenses for the use of Lonza’s proprietary Protein Free Media System for both research and development as well as commercial purposes. The Agreement includes license fees and milestone payments, the financial terms of which have not been disclosed.
"Lonza is pleased to enter into this agreement with Genentech. We believe that having Lonza’s GS Gene Expression System selected by one of the leaders in the development and manufacture of biopharmaceuticals underscores the importance of this technology for the efficient production of therapeutic antibodies and recombinant proteins” said Karen Fallen, Lonza’s Commercial License Manager.
About Lonza
Lonza, a chemical and biotechnology company driven by the life sciences, generated sales of CHF 2.52 billion in 2005. Headquartered in Switzerland, Lonza operates 21 production and R&D sites around the world. Its 6000 employees are passionately com-mitted to delivering sustainable value to their customers. Lonza is one of the leading custom manufacturers of chemical intermediates, active ingredients and biopharma-ceuticals for the pharmaceutical and agrochemical industries. On the basis of organic chemical, oleochemical and biotechnology platforms, Lonza creates value-added solu-tions for the nutrition, hygiene & personal care, wood & water treatment and industrial specialty markets. Lonza also offers polymer intermediates, resins and compounds. Further information can be found on our website www.lonza.com.
For further information:
Media Relations
Christine Menz
Tel +41 61 316 8253
Fax +41 61 316 9253
christine.menz@lonza.com
Investor Relations
Laura Gerber
Tel +41 61 316 8347
Fax +41 61 316 8220
laura.gerber@lonza.com |
|
|
